News | Flat Panel Displays | October 14, 2015

5MP, 21-inch color LED-backlit display offers high resolution and advanced features

Quest International, Totoku CCL550i2 diagnostic display, FFDM approval, full-field digital mammography, breast imaging applications

Image courtesy of Totoku


October 14, 2015 — Quest International Inc. announced the availability of the Totoku CCL550i2 color diagnostic display from JVC Kenwood. The newly announced 5MP (megapixel) display is the first color 5MP diagnostic display that has been granted 510(k) full-field digital mammography (FFDM) approval by the U.S. Food and Drug Administration for use in all digital mammography applications.

The CCL550i2 is a 5-megapixel high-bright, color LED-backlit LCD designed for both picture archiving and communication system (PACS) and breast imaging, eliminating the need for other multi-head display configurations or needing to move to another workstation to view additional studies.

Features of the Totoku CCL550i2 include:
            - 5MP high resolution color diagnostic display
            - 21.3-inch color TFT IPS technology display panel
            - LED backlight technology
            - 1000 cd/m² maximum luminance, calibrated to 410 cd/m² luminance
            - Front luminance sensors
            - Dual input (DisplayPort and DVI-D) interface

The Totoku CCL550i2 is currently available from Quest International. The unit is backed by Quest International through a five-year warranty. Available exclusively from Quest International is an optional advanced exchange warranty option on the monitor.

Located in Irvine, California, Quest International serves as a master distributor and authorized service center for Totoku Medical Displays in North America.

For more information: www.totoku.com


Additional Content

News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Women's Health

Oct. 15, 2026— SimBioSys has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of TumorSight Risk, its ...

Time October 19, 2026
arrow
News | Breast Imaging

Oct. 6, 2026 — The American College of Radiology (ACR) has recognized Mercy Medical Center’s Tyanna O’Brien Center for ...

Time October 09, 2026
arrow
News | Ultrasound Women's Health

Sept. 29, 2026 — A research team at the University of Virginia (UVA) led by Timothy Bullock, PhD, has published results ...

Time September 30, 2026
arrow
Subscribe Now